Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDLiminatus Pharma Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 03/31/2026 | Q4 2025 | N/A | -$0.30 | N/A | N/A | $0 |
| 11/13/2025 | Q3 2025 | N/A | -$0.07 | N/A | N/A | $0 |
| 10/03/2025 | Q2 2025 | N/A | $0.00 | N/A | N/A | $0 |
| 05/30/2025 | Q1 2025 | N/A | -$2.55 | N/A | N/A | $0 |
| 12/30/2024 | Q4 2024 | N/A | -$0.12 | N/A | N/A | $0 |
| 09/29/2024 | Q3 2024 | N/A | -$0.09 | N/A | N/A | $0 |
| 06/29/2024 | Q2 2024 | N/A | -$0.07 | N/A | N/A | $0 |
| 03/31/2024 | Q1 2024 | N/A | -$0.23 | N/A | N/A | $0 |
| 12/31/2023 | Q4 2023 | N/A | -$0.07 | N/A | N/A | $0 |
| 09/29/2023 | Q3 2023 | N/A | -$0.04 | N/A | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Liminatus Pharma Inc. Earnings: FAQ's
The conference call for Liminatus Pharma Inc.'s latest earnings report can be listened to online.
The conference call transcript for Liminatus Pharma Inc.'s latest earnings report can be read online.
Liminatus Pharma Inc. (:LIMN) has a recorded net income of $-10,206,517.Liminatus Pharma Inc. has generated $-0.43 earnings per share over the last four quarters.
Liminatus Pharma Inc. (:LIMN) has a price-to-earnings ratio of -0.5 and price/earnings-to-growth ratio is 0.